-
with a PhD in Engineering (or close to completion) may apply. You will be responsible for: Design of the first reconfigurable robotic matter in collaboration with world-leading universities and
-
that fosters regular discussion and interdisciplinary exchange. We welcome applications from highly motivated, creative individuals with a deep interest in immunology and a strong publication record. A PhD (or
-
-funded project entitled “Accelerated Development of Next Generation Li-Rich 3D Cathode Materials (3D-CAT)”. You will have a PhD (or be near completion) in materials or chemistry and experience in battery
-
of the research group, including postdocs, research assistants, technicians, PhD and project students, as well as to represent the PI and ISML when required. You will hold a Masters or PhD degree (or be close to
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with sufficient specialist knowledge in normal and malignant
-
% FTE The successful candidate will hold a Master’s or PhD degree in a Social Science or Science disciplin,e demonstrating strong quantitative data analysis skills. Current PhD students studying part-time
-
screening (XChem), PDB deposition and biophysical techniques including SPR, DSF and NMR. Applicants must hold a PhD in Biochemistry/ Biophysics / Chemical Crystallography or a related field (or have submitted
-
facilely applied as a photoluminescent layer, targeting in situ detection and non-contact visualization of surface temperatures and pressures. You should hold a PhD/DPhil (or near completion*) in materials
-
of agentic behaviour and publishing high-impact research. Candidates should possess a PhD (or be near completion) in PhD in Computer Science, AI, Security, or a related field. You will have a Strong background
-
and how it may respond to vaccination. You will supervise master’s and PhD students, and support the overall efforts of the lab. This post offers the opportunity to engage in cutting-edge translational